AtoQuegen

A SC-glucan rich AtoQuegen® cream provides intensive hydrating effects over time revealing a luminescent complexion with its creamy formula

The main ingredients of Atoquegen

Beta-glucan of Schizophyllum commune (SC-glucan)
SC-glucan is produced in our own factory, has a powerful hydration effect, acts as a skin sedative, and is renewable and is anti-carcinogenic.

Mandarin oil
The main chemical components of mandarin oil are limonene with a powerful anti-microbial effect and useful bio-active fl avonoids.

COS-PA Liposome
COS-PA liposome is a combination of Phytosphingosine and vitamin C, has anti-fungal and skin intensifi cation effects.

Extract of Lithospermi radix
Extract of L. radix has anti-microbial/inflammatory effects, and is a alleviation molecule for skin irritations.

Properties of Atoquegen

• Use of natural substances (steroid free)
• Powerful moisturizing effect to dry and sensitive skins
• Skin sedative effect
• Anti-microbial effect

SC-glucan

SC-glucan is a kind of β-glucan, a neutral extracellular polysaccharide produced by the fungus Schizophyllum commune consisting of a 1,3-β-D-linked backbone of glucose residues with 1,6-β-D-glucosyl side groups. The non-degraded polysaccharide has a molecular weight of the order 106 Da

Features of SC-glucan

• Skin moisturizing
• Skin sedative
• Anti-cancer molecule
• Inducing of collagen biosynthesis
• Burn and Wound healing

Moisturizing effect

Skin sedative effect

QueGen Biotech

• QueGen Biotech Co., Ltd. was established in 2006 for production of highly effective bio-molecules for cosmetics and health foods.
• The QueGen Biotech is equipped with microbial fermentation facilities of 10 ton scale for mass production of high functional materials using high biotechnology.
• The QueGen Biotech has several important patents. Also our R&D center is developing higher-valued biomolecules by liquid fermentation.
• The QueGen Biotech has succeeded in bio-renewable process development in cooperation with Jeju Hi-Tech Development Industry Institute.

Patents

• β-1,6-branched-1,3-glucan high-yielding strain, Schizophyllum commune QG143-1 (KR10-2007-0093013)
  
• Large-scale production of β-1,6-branched- β-1,3-glucan using semi-continuous fermentation performed with Schizophyllum commune (KR10-2008-0001554)
• Application of β-1,6-branched- β-1,3-glucan from Schizophyllum commune Fr. For ingredient of ophthalmic solution (KR10-2007-0088262)